Results 111 to 120 of about 2,864 (172)

Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France. [PDF]

Emerg Infect Dis
Poignon C, Vandenbos F, Risso K, Viard D, Gydé E, Gaudart A, Chirio D, Veziris N, Carles M.   +8 more
europepmc   +1 more source

Management of adverse events in TB care and active TB drug safety monitoring. [PDF]

Breathe (Sheff)
Ma'aruf SY, Sharma A, Fox S, Duarte R, Lange C, Tiberi S.   +5 more
europepmc   +1 more source

The time is now: making the case for compassionate use/pre-approval access to new TB drugs. [PDF]

IJTLD Open
Reuter A, Stillo J, Thi SS, Motta I, Migliori GB, Mesic A, Mbenga M, Howell P, Guglielmetti L, Gebhard A, DeCroo T, D'Ambrosio L, Furin J.   +12 more
europepmc   +1 more source

Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia. [PDF]

Commun Med (Lond)
Diriba G, Mollalign H, Meaza A, Getu M, Zerihun B, Alemu A, Dagne B, Abebaw Y, Weldemariam AG, Bashea C, Ali A, Seid G, Getahun M, Hailu M, Wondimu A, Getachew T, Kumsa A, Letta T, Liaulseged A, Abera NA, Abate Z, Alemu E, Challa F, Tadesse G, Abdella S, Tollera G, Dangisso MH.   +26 more
europepmc   +1 more source

Maternal, Pregnancy, and Infant Outcomes in Women Treated for Multidrug-Resistant/Rifampicin-Resistant Tuberculosis With Novel and Repurposed Drugs in KwaZulu-Natal, South Africa. [PDF]

Clin Infect Dis
Loveday M, Hughes J, Mchunu N, Yende-Zuma N, Holloway K, Hlangu S, Chotoo S, Singh N, Seddon JA.   +8 more
europepmc   +1 more source

Success rates of DR-TB patients and associated factors in Tanzania: a six-year cohort study. [PDF]

BMC Infect Dis
Lyakurwa DM, Lekule IA, Mziray SR, Balama RF, Sililo G, Kisonga RM, Yao W, Ai F.   +7 more
europepmc   +1 more source

Rifampicin-resistant tuberculosis in Spain. [PDF]

ERJ Open Res
García-García JM, Rodrigo-Sanz T, Gullón-Blanco JA, Casas García X, Millet JP, Quirós Fernández S, Martínez Lirola MJ, Mangas Moro A, Domínguez Castellano Á, Navas Elorza E, Nieto Marcos M, Arasa Panisello F, Bermúdez Ruiz P, García Cabrera M, Sanz Herrero F, Suárez Toste I, Urrelo Cerrón LA, Espiau Guarner M, Soriano Arandes A, Arias Guillén M, Cebrián Gallardo JJ, García-Fuertes JA, Pérez-Jacoiste Asín MA, Somoza González M, Palacios Gutiérrez JJ, Alcaide F, Samper Blasco S, Tabernero Huguet E, Caylà JA, Ruiz Manzano J, Caminero Luna JA, Working Group on Rifampicin Resistant Tuberculosis of the Tuberculosis Research Programme (PII-TB) SEPAR .   +31 more
europepmc   +1 more source

Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice. [PDF]

J Infect Dis
Lee BY, Clemens DL, Masleša-Galic S, Nava S, Lo CY, Zink JI, Horwitz MA.   +6 more
europepmc   +1 more source

Current Status and Perspectives of Antibacterial Agents Belonging to 2-Oxazolidinones. [PDF]

Pharmaceuticals (Basel)
Ceramella J, Mariconda A, Iacopetta D, Marra M, Catalano A, Checconi P, Aquaro S, Saturnino C, Longo P, Sinicropi MS.   +9 more
europepmc   +1 more source